Hbv immune checkpoint receptor cd33 ( siglec-3) is a promising therapeutic target for chronic hepatitis b infectionPei-Shan Sung,Chieh-Ju Lee,Yi-Hsiang Huang,Chang-Ru Wu,Shie-Liang HsiehHEPATOLOGY(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要